Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The National Academy of Personal Injury Attorneys Awards Jason T. Brown Top 10 Attorney Award
  • USA - English


News provided by

JTB Law Group, LLC

Jan 31, 2014, 18:00 ET

Share this article

Share toX

Share this article

Share toX

Jason T. Brown with Jury
Jason T. Brown with Jury

The evildoers never sleep and neither do we.

Post this

Jersey City, NJ (PRWEB) January 31, 2014 -- On January 31, 2014, The National Academy of Personal Injury Attorneys Awarded Jason T. Brown a Top 10 Attorney Award for his tireless work and results litigating matters on behalf of injured Plaintiffs. Mr. Brown commented, “It is an honor to receive this award and to know all the long hours and hard work we put in fighting for people’s rights bear fruit for our clients and bestow upon on this distinction. We will continue to push hard for the new year and if one follows our achievements there are many exciting announcements the firm with have in the coming weeks.”

The National Academy of Personal Injury Attorneys (“NAOPIA”) is an organization devoted to recognizing the top Personal Injury attorneys in the nation. With over a million attorneys in the United States, choosing the best lawyer is difficult. However, through a stringent selection process, the NAOPIA awards the best Personal Injury attorneys in each state with our most prestigious honor of "TOP 10". The very few attorneys (less than 1%) that are good enough to make the list have demonstrated an extraordinary amount of knowledge, skill, experience, expertise and success in their practice of Personal Injury. NAOPIA’s research staff verifies that they meet the requirements of membership. Then they have to advance to the final selection stage by a processing committee. And, finally they have to be selected by a Board of Governors as the "TOP 10". As NAOPIA states, “We know it is a tough process but we wouldn't have it any other way.”

Jason T. Brown was formerly a Special Agent and Legal Advisor with the Federal Bureau of Investigation (FBI). After serving as an Agent in very high profile cases he became managing partner of a Manhattan based law firm that handled mass torts and class actions. Now he heads a firm that fights for people’s rights nationwide. “The evildoers never sleep and neither do we.” Brown stated. “Complex litigation is intense but rewarding and we love leveling the playing field against some of the biggest companies represented by the most powerful law firms. I enjoy the challenge and have the energy and desire to win. The bigger they are, the harder the fall.”

Mr. Brown is noted for commencing some of the first lawsuits against new generation birth control products which he alleges may be less safe than earlier generations. The bulk of the litigation surrounding the product Nuvaring originated with Attorney Brown and he currently represents in conjunction with co-counsel over 400 women who allegedly sustained life altering blood clots, like Deep Vein Thrombosis (DVT), Pulmonary Embolisms (PE), or death from the alleged use of the product. The formal case is In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.

“As a consumer advocate, I remain extremely concerned about the new generation of hormonal products that are ‘tested’ on young women everywhere,” Brown stated. One of the litigations that he remains active in is the Yasmin litigation which has resulted in over a billion dollars of recoveries for women who allegedly sustained blood clots, like deep vein thrombosis, pulmonary embolisms, strokes, sagital venous thrombosis, blindness or death. The allegations stem from a hormone within such products as Yaz, Yasmin, Ocella, Gianvi and BeYaz which Mr. Brown alleges are twice as deadly as earlier generations of birth control. “New products should be safer, not less safe,” Mr. Brown states, “The pharmaceutical companies should come up with products that have half the risk as earlier generation, not double the risk. The FDA is asleep at the helm.” The Yasmin/Yaz Multidistrict Litigation is found at (MDL 2100, US District Court, Southern District of Illinois).

Other products liability cases the firm handles include investigations into alleged injuries from the Da Vinci Surgical Robot, by Intuitive Surgical who received an FDA warning letter (http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2013/ucm363260.htm) and which allegedly has been linked to sepsis, burning, excessive bleeding, burns and tears, and internal organ damage. Trans Vaginal Mesh erosion which may require revision surgery to correct, which has a docket in West Virginia (2:12-md-02325). Benicar usage which may allegedly cause intestinal problems like Sprue-like Enteropathy which may result in rapid significant weight loss or death and the FDA has recently warned about (http://www.fda.gov/drugs/drugsafety/ucm359477.htm). Mesothelioma from exposure to Asbestos. Alleged gynecomastia from use of Risperdal as a minor requiring surgical correction of the breasts which is in Philadelphia Court of Common Pleas Docket 100300296. Birth defects like lung or heart damage requiring surgery allegedly from the use of SSRI products like (MDL 2342) Zoloft, Topamax, Celexa, Paxil, Effexor, Lexapro and Prozac during the first trimester and the alleged link between the use of Actos and bladder cancer. (Actos® Multidistrict Litigation (MDL 2299).

The firm also handles a variety of class actions, especially on behalf of workers who are not fully paid for all the hours worked or abruptly terminated en masse (WARN ACT). “You should be fully paid for all the hours you work and employers try many elaborate schemes to lower compensation, short pay and not pay proper overtime wages.” Specific violations he points to are when workers are improperly paid a day rate or salary instead of overtime, which he indicates is prevalent in certain industries especially the oil and gas rigs and with mud loggers. The firm also handles other high profile and catastrophic cases and travels nationwide to prosecute cases in conjunction with local counsel. Mr. Brown currently has cases pending in over ten different states and will fly or litigate all over the country to meet with a client if he believes in the case. Through all the success he has had, the many multi-million dollar results, Mr. Brown remains humble and "honored to receive recognition for the quality of our litigation."

Office Manager, JTB Law Group, LLC, http://www.ifightforyourrights.com/, +1 (877) 561-0000, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.